Cargando…

Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway

Detalles Bibliográficos
Autores principales: Fang, Chao, Chen, Yi-Xin, Wu, Na-Yiyuan, Yin, Ji-Ye, Li, Xiang-Ping, Huang, Hsuan-Shun, Zhang, Wei, Zhou, Hong-Hao, Liu, Zhao-Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586360/
https://www.ncbi.nlm.nih.gov/pubmed/34764341
http://dx.doi.org/10.1038/s41598-021-01417-w
_version_ 1784597875487932416
author Fang, Chao
Chen, Yi-Xin
Wu, Na-Yiyuan
Yin, Ji-Ye
Li, Xiang-Ping
Huang, Hsuan-Shun
Zhang, Wei
Zhou, Hong-Hao
Liu, Zhao-Qian
author_facet Fang, Chao
Chen, Yi-Xin
Wu, Na-Yiyuan
Yin, Ji-Ye
Li, Xiang-Ping
Huang, Hsuan-Shun
Zhang, Wei
Zhou, Hong-Hao
Liu, Zhao-Qian
author_sort Fang, Chao
collection PubMed
description
format Online
Article
Text
id pubmed-8586360
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85863602021-11-16 Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway Fang, Chao Chen, Yi-Xin Wu, Na-Yiyuan Yin, Ji-Ye Li, Xiang-Ping Huang, Hsuan-Shun Zhang, Wei Zhou, Hong-Hao Liu, Zhao-Qian Sci Rep Author Correction Nature Publishing Group UK 2021-11-11 /pmc/articles/PMC8586360/ /pubmed/34764341 http://dx.doi.org/10.1038/s41598-021-01417-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Fang, Chao
Chen, Yi-Xin
Wu, Na-Yiyuan
Yin, Ji-Ye
Li, Xiang-Ping
Huang, Hsuan-Shun
Zhang, Wei
Zhou, Hong-Hao
Liu, Zhao-Qian
Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
title Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
title_full Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
title_fullStr Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
title_full_unstemmed Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
title_short Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
title_sort author correction: mir-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (nsclc) cells by activating the eif3a-mediated ner signaling pathway
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586360/
https://www.ncbi.nlm.nih.gov/pubmed/34764341
http://dx.doi.org/10.1038/s41598-021-01417-w
work_keys_str_mv AT fangchao authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway
AT chenyixin authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway
AT wunayiyuan authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway
AT yinjiye authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway
AT lixiangping authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway
AT huanghsuanshun authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway
AT zhangwei authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway
AT zhouhonghao authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway
AT liuzhaoqian authorcorrectionmir488inhibitsproliferationandcisplatinsensibilityinnonsmallcelllungcancernsclccellsbyactivatingtheeif3amediatednersignalingpathway